Nox

Nonprofit Supporting Retired Military Working Dogs Celebrates Milestone

Retrieved on: 
Thursday, April 4, 2024
Ankle, Dog, United States Army, Emergency, Pain, Nox, Pharmaceutical industry

BALTIMORE, April 04, 2024 (GLOBE NEWSWIRE) -- A non-profit with over 23 years’ service, supporting the military K-9 community, is celebrating the successful rollout of a new program which covers the cost of emergency treatments for retired military working dogs.

Key Points: 
  • BALTIMORE, April 04, 2024 (GLOBE NEWSWIRE) -- A non-profit with over 23 years’ service, supporting the military K-9 community, is celebrating the successful rollout of a new program which covers the cost of emergency treatments for retired military working dogs.
  • US War Dogs Association has already provided $50,000 of treatments to retired MWDs through its Emergency Care program, alleviating the financial burden from their handlers and families.
  • Retired US Army patrol and explosive detection dog (PEDD), Nox, is a recent beneficiary of US War Dogs’ Emergency Care program.
  • “We are only able to continue our vital work of supporting the military K-9 community, thanks to the generosity of our donors.

BAM Capital Partners with Milhaus to Launch Nox, A New Era in Multifamily Living in Pittsburgh, PA

Retrieved on: 
Thursday, March 14, 2024
Partnership, Nox, Millhouse, Barratt, Commercial property

Founded on a commitment to integrity, innovation, and excellence, BAM Capital has established itself as a leader in the multifamily real estate sector .

Key Points: 
  • Founded on a commitment to integrity, innovation, and excellence, BAM Capital has established itself as a leader in the multifamily real estate sector .
  • Milhaus, a premier real estate development and management company, brings its expertise in creating high-quality, sustainable urban housing solutions.
  • Their partnership with BAM Capital in developing Nox underscores a shared vision for excellence and a commitment to positively impacting the communities they serve.
  • "BAM Capital remains highly selective and opportunistic in its ongoing endeavor to be the most trusted steward of investor capital," notes Ivan Barratt, Founder and CEO of BAM Capital.

Nox Health Appoints Emily Buxton Taylor as Chief Financial & Operating Officer

Retrieved on: 
Wednesday, November 15, 2023
Sleep, CFO, Conditional sentence, Financial Executives International, Health, FEI, Nox, Kristjánsson, Management, Nursing

ALPHARETTA, Ga., Nov. 15, 2023 /PRNewswire/ -- Nox Health, a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced that it has named Emily Buxton Taylor as Chief Financial & Operating Officer.

Key Points: 
  • ALPHARETTA, Ga., Nov. 15, 2023 /PRNewswire/ -- Nox Health , a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced that it has named Emily Buxton Taylor as Chief Financial & Operating Officer.
  • "I am delighted to join Nox Health and have been impressed with the team's passion for sleep," said Emily Buxton Taylor, Chief Financial and Operating Officer, Nox Health.
  • Emily most recently served as Chief Operating Officer and Chief Financial Officer of Wondr Health, a company that offers complete weight and stress management programs.
  • Previously, Emily held numerous financial positions, including Chief Financial Officer at Paradigm Tax and National HME, Chief Accounting Officer at Northstar Anesthesia, and Chief Financial Officer at Orthofix Medical, Inc. She is a certified public accountant and an active member of Financial Executives International (FEI).

Nox Health Appoints Frances Thorndike, Ph.D. to lead Medical & Scientific Affairs

Retrieved on: 
Thursday, November 9, 2023
Sleep, Acquisition, Research, Therapy, Assistant professor, Patient, Medicine, Doctor of Philosophy, FDA, Medical Affairs Bureau, Science, Psychiatry, Frances Cope, Nox, University, Insomnia, Discovery, Pharmaceutical industry, Nursing

ALPHARETTA, Ga., Nov. 9, 2023 /PRNewswire/ -- Nox Health, a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced the appointment of Frances Thorndike, Ph.D. to the Nox Health team as Vice President of Medical & Scientific Affairs.

Key Points: 
  • A pioneer who helped create Somryst, the first FDA-cleared prescription digital therapeutic for chronic insomnia, Dr. Thorndike brings deep expertise in insomnia, health economics and outcomes research to the Nox team
    ALPHARETTA, Ga., Nov. 9, 2023 /PRNewswire/ -- Nox Health , a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced the appointment of Frances Thorndike, Ph.D. to the Nox Health team as Vice President of Medical & Scientific Affairs.
  • Dr. Thorndike brings deep expertise in insomnia, health economics and outcomes research to the Nox team.
  • Dr. Thorndike joins Nox Health from Pear Therapeutics, where she most recently served as Vice President, Medical Affairs and Discovery, and led the clinical effort for FDA authorization of Somryst, the first FDA-cleared prescription digital therapeutic for chronic insomnia.
  • "Given my work in the sleep care space for the past 19 years, I have known and held deep respect for SK and the Nox Health team for some time and we share the same passion for the science of sleep, as well as the importance of using sleep to address chronic health conditions," said Frances Thorndike, Ph.D. Vice President of Medical & Scientific Affairs, Nox Health.

Nox Health Expands Board of Directors

Retrieved on: 
Wednesday, November 1, 2023
Dignity, Fertility, Nox, Telehealth, Obesity, SVP, CommonSpirit Health, Physician, Consultant, Diabetes, Health, Central Waqf Council, Clinic, Concentra, WebMD, Hypertension, Executive, Dignity Health, Smart, Sleep, Sleep deprivation, Fortune 500, Management, Humana

ALPHARETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nox Health , a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced the appointment of three new board members: Lloyd Dean, Chief Executive Emeritus & Founding Executive, CommonSpirit Health; David Schlanger, Executive Chairman, Progyny; Dr. Bill Lewis, Telehealth Consultant to Fortune 500 companies.

Key Points: 
  • ALPHARETTA, Ga., Nov. 01, 2023 (GLOBE NEWSWIRE) -- Nox Health , a global sleep health leader in sleep diagnostics and value-based sleep care management, today announced the appointment of three new board members: Lloyd Dean, Chief Executive Emeritus & Founding Executive, CommonSpirit Health; David Schlanger, Executive Chairman, Progyny; Dr. Bill Lewis, Telehealth Consultant to Fortune 500 companies.
  • “Sleep is the missing gap in care central to all chronic conditions,” said Sigurjon Kristjanson, CEO Nox Health.
  • He led CommonSpirit Health and Dignity Health through significant strategic, operational, and financial transformations to its current status as a leading health care organization recognized for high quality, compassionate care, operational excellence and successful financial results.
  • Dr. Bill Lewis commented: “I am proud to join the Board of Directors of Nox Health, a purpose-driven company that is focused on enabling access and improving outcomes, issues that I have dedicated my career to addressing.”

Nox Management Expands Portfolio with Trampo Extreme Acquisition

Retrieved on: 
Tuesday, October 10, 2023
Entertainment, GCC, F&B, Acquisition, CITY, Retail, Nox

KUWAIT CITY, Oct. 10, 2023 /PRNewswire/ -- Kuwait-based Nox Management acquires Trampo Extreme, a renowned entertainment and adventure enterprise spanning across Kuwait, UAE, Bahrain, Qatar, and Oman.

Key Points: 
  • KUWAIT CITY, Oct. 10, 2023 /PRNewswire/ -- Kuwait-based Nox Management acquires Trampo Extreme, a renowned entertainment and adventure enterprise spanning across Kuwait, UAE, Bahrain, Qatar, and Oman.
  • This strategic move marks a pivotal milestone in Nox Management's ambitious growth and expansion strategy.
  • Trampo Extreme, synonymous with exhilarating trampoline parks, adventure attractions, and family-friendly entertainment, has been an award-winning regional industry icon since its inception in 2015.
  • Marzouq Jassim Al-Bahar, CEO of Nox Management, commented, "As part of our strategy to diversify our F&B-focused portfolio, we acquired Trampo Extreme to address an unmet, fragmented market and elevate the entertainment offering in the region.

Nox Management Expands Portfolio with Trampo Extreme Acquisition

Retrieved on: 
Tuesday, October 10, 2023
Entertainment, GCC, F&B, Acquisition, CITY, Retail, Nox

KUWAIT CITY, Oct. 10, 2023 /PRNewswire/ -- Kuwait-based Nox Management acquires Trampo Extreme, a renowned entertainment and adventure enterprise spanning across Kuwait, UAE, Bahrain, Qatar, and Oman.

Key Points: 
  • KUWAIT CITY, Oct. 10, 2023 /PRNewswire/ -- Kuwait-based Nox Management acquires Trampo Extreme, a renowned entertainment and adventure enterprise spanning across Kuwait, UAE, Bahrain, Qatar, and Oman.
  • This strategic move marks a pivotal milestone in Nox Management's ambitious growth and expansion strategy.
  • Trampo Extreme, synonymous with exhilarating trampoline parks, adventure attractions, and family-friendly entertainment, has been an award-winning regional industry icon since its inception in 2015.
  • Marzouq Jassim Al-Bahar, CEO of Nox Management, commented, "As part of our strategy to diversify our F&B-focused portfolio, we acquired Trampo Extreme to address an unmet, fragmented market and elevate the entertainment offering in the region.

Nox Health Names Brigitte Nettesheim as President, Enterprise

Retrieved on: 
Monday, September 11, 2023
United States service academies, ACO, United States Department of the Army, Sleep, Kellogg School, Nox, National accounts, Growth, Health, Northwestern University, Economics, Management, Science

ALPHARETTA, Ga., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Nox Health , a global leader in sleep diagnostics and value-based sleep care management, today announced that Brigitte Nettesheim has been appointed President, Nox Health, Enterprise business, effective immediately.

Key Points: 
  • ALPHARETTA, Ga., Sept. 11, 2023 (GLOBE NEWSWIRE) -- Nox Health , a global leader in sleep diagnostics and value-based sleep care management, today announced that Brigitte Nettesheim has been appointed President, Nox Health, Enterprise business, effective immediately.
  • In this role, Brigitte will have responsibility for Nox Health’s value-based sleep care management business, which provides plan sponsors and health plans the means to improve the health of their populations suffering from chronic conditions.
  • Brigitte joins Nox from Aetna, a CVS Health Company, where she has spent the majority of her career in positions of increasing responsibility.
  • “Brigitte brings a unique understanding of the employee benefits marketplace, and the needs of plan sponsors who are looking for specialty networks to manage costs and improve the health of their members.”
    “Sleep is a missing but foundational gap in care, inextricably linked to the chronic conditions which drive plan sponsor and health plan costs,” said Brigitte Nettesheim, President Nox Health, Enterprise division.

ZeroNox Registration Statement Related to Business Combination with The Growth for Good Acquisition Corp. Declared Effective by SEC

Retrieved on: 
Monday, August 7, 2023
Other Energy, Automotive, General Automotive, Transport, Alternative Energy, Energy, Other Transport, Slate, Good, Eastern Time Zone, Nox, Cyprus Securities and Exchange Commission, Skadden, Arps, Slate, Meagher & Flom, Form, Deep Decarbonization Pathways Project, Security (finance), One Manhattan West, Growth

The Growth for Good Acquisition Corporation [NASDAQ: GFGD) (“Growth for Good”), today announced that its Registration Statement on Form S-4 in connection with the previously announced business combination with Zero Nox Inc. (“ZeroNox” or the “Company”), a leading provider of sustainable, off-highway vehicle electrification, has been declared effective by the Securities and Exchange Commission (the “SEC”).

Key Points: 
  • The Growth for Good Acquisition Corporation [NASDAQ: GFGD) (“Growth for Good”), today announced that its Registration Statement on Form S-4 in connection with the previously announced business combination with Zero Nox Inc. (“ZeroNox” or the “Company”), a leading provider of sustainable, off-highway vehicle electrification, has been declared effective by the Securities and Exchange Commission (the “SEC”).
  • Growth for Good has set August 23, 2023 at 10:00 a.m., Eastern Time for an extraordinary general meeting of shareholders to approve the proposals associated with the business combination.
  • The boards of directors of ZeroNox and Growth for Good have unanimously approved the business combination.
  • ZeroNox is entering the public markets at a critical juncture, and has numerous tailwinds supporting its growth objectives within the off-highway vehicle market.”

Nox Health Acquires Somryst, the Only FDA-Cleared Digital Insomnia Treatment

Retrieved on: 
Thursday, May 25, 2023
Complaint, Sleep, DSM-IV codes, Digital, PDT, FDA, Acquisition, Patient, Nox, Pharmaceutical industry, Nursing, Insomnia

ALPHARETTA, Ga. , May 25, 2023 (GLOBE NEWSWIRE) -- Nox Health , a global sleep health leader, has acquired Somryst, the first FDA-cleared Prescription Digital Therapeutic (PDT) that delivers effective, first-line treatment for adults with chronic insomnia.

Key Points: 
  • ALPHARETTA, Ga. , May 25, 2023 (GLOBE NEWSWIRE) -- Nox Health , a global sleep health leader, has acquired Somryst, the first FDA-cleared Prescription Digital Therapeutic (PDT) that delivers effective, first-line treatment for adults with chronic insomnia.
  • This acquisition deepens the Nox value-based healthcare programs, as it seeks to reframe sleep as a critical and powerful intervention strategy for chronic health conditions management.
  • By delivering CBT-I via a mobile application, Somryst offers health care providers a novel treatment delivery modality to enhance the treatment of chronic insomnia for patients who lack access to clinician-delivered CBT-I.
  • Pivotal study results show that over 40% of Somryst-treated patients no longer met criteria for chronic insomnia post- treatment, and over 60% demonstrated a clinically meaningful insomnia treatment response with no adverse events reported.